Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2012

View Archived Issues

Merck & Co. patents new hPDK1 inhibitors

New agents for respiratory and other disorders patented by RespiVert

Treatment duration shortened using combination therapy for HCV

Transgene presents preclinical results for new therapeutic Ad5-based HBV vaccine

Novel arginase inhibitors prepared at Mars

Inhibitors of H-PGDS prove effective for asthma therapy

Novel potassium channel blockers disclosed by Merck & Co.

Scientists at Merck & Co. produce new mGlu5 receptor modulators

Japanese scientists discover novel protein kinase inhibitors

Takeda launches Azilva in Japan

CHMP supports monotherapy indication for Eisai's antiepileptic agent Zonegran

EMA recommends approval for AMPA receptor antagonist Fycompa

Poteligeo injection launched in Japan for adult T-cell leukemia-lymphoma

Shionogi launches injectable oxycodone product in Japan

Meiji Seika Pharma licenses COPD drug rights in Japan

Octreotide tested in patients with severe acute pancreatitis

FDA approves Absorica for severe recalcitrant nodular acne

Kalydeco recommended for E.U. approval

Anti-hepatitis C virus activity observed with raloxifene

European CHMP recommends approval of Jentadueto

Summit commences trial of potential disease-modifying drug for Duchenne muscular dystrophy

Ferring and Kyowa Hakko Kirin to copromote nocturnal enuresis drug in Japan

EMA grants positive opinion to Pfizer's Inlyta for kidney cancer

Pfizer's Xalkori capsules now available in Japan for ALK-positive NSCLC

NICE publishes new guideline regarding prescription of opioids for palliative care

ULISES 008 study misses primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...